Hepatitis Monthly

Published by: Kowsar

The Efficacy of Silymarin in Decreasing Transaminase Activities in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial

Ali Akbar Hajaghamohammadi 1 , Amir Ziaee 2 , * and Ramin Rafiei 1
Authors Information
1 Metabolic Disease Research Center, Qazvin University of Medical Sciences, Qazvin, IR.Iran
2 Metabolic Disease Research Center, Qazvin University of Medical Sciences, aziaee1963@yahoo.com, Qazvin, IR.Iran
Article information
  • Hepatitis Monthly: , 8 (3); 191-195
  • Article Type: Research Article
  • Received: May 4, 2008
  • Accepted: August 18, 2008

To Cite: Hajaghamohammadi A, Ziaee A, Rafiei R. The Efficacy of Silymarin in Decreasing Transaminase Activities in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial, Hepat Mon. Online ahead of Print ;8(3):191-195.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments